Skip to content

ADV PLASTIC SURGERY

Active Private limited companyfounded 2007active for 19 yearsEmile Bouilliotstraat 48, 1050 IxellesKBO/BCE: BE 0890.215.421

Lifetime

18 annual accounts with figures on one time axis
peak €135,396 (2023)
€32,674▼ 61.5%
lowest -€206,383 (2016)
-€7,195▼ €40,569
peak €177,398 (2024)
€125,563▼ 29.2%
€180,797▼ 20.5%
peak 0.6 FTE (2008)
-not published
Board2 names since 2007
1 directorDE VOOGHT Axel
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Gross margin from €84,835 to €32,674Loss of €7,195Dividend €44,640Equity from €177,398 to €125,563Debts from €227,435 to €180,797Cash from €1,573 to €17,000

Key points

from the 2025 annual accounts

Equity

€125,563 ▼ 29.2%
177,3982024-7,195Loss-44,640Dividend125,5632025

ADV PLASTIC SURGERY paid out €44,640 in dividends in a year with a loss of €7,195.

Filings

18 annual accounts since 2008
AprilJune31 JulyOctober2010201520202025

Eight of the last ten came late. The 2022 accounts came latest: 331 days after the end of the period.

Position in the sector

-€7,195

Lower net result than 95% of companies in human health. Sector median €60,073 · 20,747 companies.

Checked score

90
Excellent
Financially stronger than 17% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 7.7% 01-2025: 9.4%▲ +1.7 percentage points vs 12-2024highest value 02-2025: 2.3%▼ -7.1 percentage points vs 01-2025 03-2025: 2.5%▲ +0.2 percentage points vs 02-2025 04-2025: 2.5%● unchanged vs 03-2025 05-2025: 2.3%▼ -0.2 percentage points vs 04-2025 06-2025: 2.2%▼ -0.1 percentage points vs 05-2025 07-2025: 2.2%● unchanged vs 06-2025 08-2025: 0.9%▼ -1.3 percentage points vs 07-2025 09-2025: 0.9%● unchanged vs 08-2025 10-2025: 0.9%● unchanged vs 09-2025 11-2025: 0.9%● unchanged vs 10-2025 12-2025: 0.9%● unchanged vs 11-2025 01-2026: 0.9%● unchanged vs 12-2025 02-2026: 0.9%● unchanged vs 01-2026 03-2026: 1.0%▲ +0.1 percentage points vs 02-2026 04-2026: 1.0%● unchanged vs 03-2026 05-2026: 1.0%● unchanged vs 04-2026 06-2026: 0.9%▼ -0.1 percentage points vs 05-2026 07-2026: 0.7%▼ -0.2 percentage points vs 06-2026 08-2026: 0.9%▲ +0.2 percentage points vs 07-2026 09-2026: 1.2%▲ +0.3 percentage points vs 08-2026 10-2026: 0.1%▼ -1.1 percentage points vs 09-2026lowest value 11-2026: 0.1%● unchanged vs 10-2026lowest value

Financial strength
Average

66-3equity 41.0% of total assets
34+2short-term debt 47.3% · cash 5.5%
57-22return on assets -2.3%

Score breakdown

raises risk
1 of the last 3 accounts late
Loss of €7,195 (financial year 2025)
lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €306,360
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 33% of them on solvency, 7% on liquidity, 10% on profitability and 18% on growth.

The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 6,908 companies had the same profile as ADV PLASTIC SURGERY has now. Each dot stands for 18 companies, two years later.

90.9%
were still trading
7.8%
stopped another way
1.1%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a small loss

Another 0.2% stopped without a precise date, possibly only after those two years.

That fits the bankruptcy probability of ADV PLASTIC SURGERY itself: 0.1% within 12 months.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,908 companies, not a prediction for ADV PLASTIC SURGERY. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €11,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 1.64 (1.94 in 2024), above the usual 1.5. Short-term debt is 47.3% and cash 5.5% of total assets. However, 59% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 of the last 3 accounts late
NBB · filings
lowers risk · Size: total assets €306,360
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Loss of €7,195 (financial year 2025)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
31 days early
2024
on the day
2023
156 days late
2022
331 days late
2021
128 days late
2020
88 days late
2019
105 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 111 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 6 December (4 of the last 5 accounts filed within 159 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

DV
Director, since 11-06-2007
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0890215421
Registered office moved from Grimbergen to Ixelles New registered office: Emile Bouilliotstraat 48/B13, 1050 Elsene · Previous registered office: Spaanse Lindebaan 92, 1850 Grimbergen, België · Board meeting of 28-06-2024 · Gazette deed
Purpose change · Amendment of the articles · Legal-form change · Resignations & appointments Change of role: DE VOOGHT Axel, from manager to director · “Het uitoefenen van de geneeskunde door de arts-aandeelhouder of artsen aandeelhouders op het gebied van de…” (deed in Dutch) · Gazette deed
Resignation: Dominique DOUMONT (director) General meeting of 28-12-2021 · Gazette deed
All 32 events

Comparable companies

same main activity, similar in size and age
Company
ADV PLASTIC SURGERY Ixelles €306,360 €32,674 41.0% -
DR.WIM CORNELISSEN Antwerp €337,888 €30,598 82.4% -
GVWcare Mont-Saint-Guibert €316,170 €35,973 96.8% -
CORDELIA LOSSY Brussels €326,720 €38,959 93.9% -
ANEPSY Woluwe-Saint-Lambert €406,193 €38,864 11.8% -
Dr. Nathalie Schoofs, gastro-entérologie Jodoigne €363,883 €29,999 89.4% -
Dr. Guido Ingels, Anesthesie Ghent €325,775 €28,692 99.2% -

These companies have the same main activity as ADV PLASTIC SURGERY: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €316,000 and €406,000, founded between 2004 and 2009.

Official details

Source: KBO
Status
Active since 20-06-2007Normal situation
Registered office
11 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 8 November 2026.
Activity
Specialist medical practiceNACE 86220
Joint committee
330Health institutions and services · annual accounts 2024
Establishment unit
2.163.858.5781050 Ixelles, since 20-06-2007
Financial year end
31 December
Peppol
Reachable since 21-09-2025
Company details

Annual accounts 2025

≈ €100,000estimated
€306,360▼ 24.3%
Filing
Filed on 30-06-2026, 31 days before the end of the filing period
Financials

Insights on ADV PLASTIC SURGERY

ADV PLASTIC SURGERY files the micro format. That format states no turnover. The gross margin fell from €124,732 in 2008 to €32,674 in 2025.

The balance sheet grew most from 2010 to 2012 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ADV PLASTIC SURGERY

What is the company number of ADV PLASTIC SURGERY?
The company number of ADV PLASTIC SURGERY is 0890.215.421. The VAT number is the same number with BE in front: BE 0890.215.421.
Where is ADV PLASTIC SURGERY based?
The registered office is at Emile Bouilliotstraat 48, 1050 Ixelles.Company details
What does ADV PLASTIC SURGERY do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of ADV PLASTIC SURGERY?
ADV PLASTIC SURGERY is a private limited company (BV).
When was ADV PLASTIC SURGERY founded?
ADV PLASTIC SURGERY was founded on 20-06-2007.
Is ADV PLASTIC SURGERY still active?
Yes, ADV PLASTIC SURGERY is an active enterprise in the KBO register.
How many employees does ADV PLASTIC SURGERY have?
ADV PLASTIC SURGERY had an average of 1 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
Which joint committee does ADV PLASTIC SURGERY fall under?
In its 2024 annual accounts, ADV PLASTIC SURGERY states joint committee 330 (Health institutions and services).
What is the turnover of ADV PLASTIC SURGERY?
The turnover in financial year 2025 is ≈ €100,000. This figure is estimated from the gross margin of €32,674 and 47 comparable companies (NACE 86). It probably lies between €72,000 and €140,000.
Is ADV PLASTIC SURGERY profitable?
In financial year 2025, ADV PLASTIC SURGERY made a loss of €7,195.
Where can I find the annual accounts of ADV PLASTIC SURGERY?
ADV PLASTIC SURGERY filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ADV PLASTIC SURGERY due?
ADV PLASTIC SURGERY must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.